STOCK TITAN

Cannara Biotech (LOVFF) Stock News

LOVFF OTC

Welcome to our dedicated page for Cannara Biotech news (Ticker: LOVFF), a resource for investors and traders seeking the latest updates and insights on Cannara Biotech stock.

Cannara Biotech Inc. reports developments as a vertically integrated Canadian cannabis producer trading in the U.S. as LOVFF. The company cultivates and produces premium-grade cannabis and cannabis-derivative products for the Canadian market from two large Québec facilities, with disclosed potential annual cultivation output of 100,000 kilograms.

Recurring news includes operating and financial results, cultivation-yield and capacity updates, Valleyfield facility expansion, credit-facility amendments, asset optimization, product-category launches, provincial retail listings, and equity incentive grants. Company updates also cover exchange-listing status, including its graduation to the Toronto Stock Exchange, and governance or capital-structure actions tied to its growth plans.

Rhea-AI Summary

Cannara Biotech Inc. (TSXV: LOVE, OTCQB: LOVFF) announced that Chief Financial Officer Nicholas Sosiak will present live at VirtualInvestorConferences.com on June 30 at 11:30 ET. This interactive online event allows investors to ask questions in real-time, with an archived version available afterwards. Recent highlights include receiving a sales license from Health Canada in January 2021 and acquiring a $27M facility in June 2021. Cannara operates large cannabis facilities in Quebec, offering premium-grade products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.55%
Tags
none
-
Rhea-AI Summary

Cannara Biotech Inc. has announced an agreement to acquire a fully automated one million sq. ft. cultivation and manufacturing facility from TGOD in Valleyfield, Quebec for $27 million, plus assuming liabilities of $5.7 million. This acquisition is expected to enhance Cannara's annual cultivation capacity to 125,000 kg of premium-grade cannabis. Funding will primarily come through a private equity placement at $0.18 per share. The deal is anticipated to close by June 20, 2021, further solidifying Cannara's position in the Canadian cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.55%
Tags

FAQ

What is the current stock price of Cannara Biotech (LOVFF)?

The current stock price of Cannara Biotech (LOVFF) is $1.18 as of June 10, 2026.

What is the market cap of Cannara Biotech (LOVFF)?

The market cap of Cannara Biotech (LOVFF) is approximately 116.6M.